17-31095058-G-GCC
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_001042492.3(NF1):c.-248_-247dupCC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00010 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00015 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
NF1
NM_001042492.3 5_prime_UTR
NM_001042492.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.297
Publications
0 publications found
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000101 AC: 15AN: 148626Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
15
AN:
148626
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000146 AC: 60AN: 410060Hom.: 0 Cov.: 0 AF XY: 0.000163 AC XY: 35AN XY: 214930 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
60
AN:
410060
Hom.:
Cov.:
0
AF XY:
AC XY:
35
AN XY:
214930
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
10126
American (AMR)
AF:
AC:
2
AN:
16246
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
12496
East Asian (EAS)
AF:
AC:
0
AN:
27484
South Asian (SAS)
AF:
AC:
15
AN:
40768
European-Finnish (FIN)
AF:
AC:
4
AN:
28982
Middle Eastern (MID)
AF:
AC:
0
AN:
1830
European-Non Finnish (NFE)
AF:
AC:
34
AN:
247940
Other (OTH)
AF:
AC:
2
AN:
24188
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.364
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000101 AC: 15AN: 148726Hom.: 0 Cov.: 31 AF XY: 0.0000552 AC XY: 4AN XY: 72522 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
15
AN:
148726
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
72522
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
3
AN:
40394
American (AMR)
AF:
AC:
4
AN:
14866
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3426
East Asian (EAS)
AF:
AC:
0
AN:
5028
South Asian (SAS)
AF:
AC:
0
AN:
4712
European-Finnish (FIN)
AF:
AC:
5
AN:
10258
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3
AN:
66802
Other (OTH)
AF:
AC:
0
AN:
2056
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.288
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neurofibromatosis, type 1 Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neurofibromatosis, familial spinal Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neurofibromatosis-Noonan syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Café-au-lait macules with pulmonary stenosis Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.